Business Wire14h
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Plastics News20h
Material Insights: PP prices plunge; career advice from Nexeo’s Michelle Boven
In October, North American polypropylene resin prices experienced a significant drop of 6 cents per pound. Prices had been ...